Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

被引：0
|
作者：
John W. Ostrominski
Tiffany M. Powell-Wiley
机构：
[1] Brigham and Women’s Hospital and Harvard Medical School,Division of Cardiovascular Medicine
[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Endocrinology, Diabetes and Hypertension
[3] National Heart,Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research
[4] Lung and Blood Institute,Intramural Research Program
[5] National Institutes of Health,undefined
[6] National Institute on Minority Health and Health Disparities,undefined
[7] National Institutes of Health,undefined
来源：
Current Atherosclerosis Reports | 2024年 / 26卷
关键词：
Obesity; Cardiometabolic disease; Prevention; Weight management; Social determinants of health; Pharmacotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 23
页数：12
相关论文
共 50 条
  • [21] Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension
    Gysan, DB
    ZEITSCHRIFT FUR KARDIOLOGIE, 2002, 91 (10): : 777 - 785
  • [22] Cardiovascular Disease Prevention: The Continuum of Primary and Secondary Prevention Preface
    Deedwania, Prakash
    CARDIOLOGY CLINICS, 2011, 29 (01) : XI - XIII
  • [23] SAVE LIFE SAVE PAKISTAN THROUGH PRIMARY PREVENTION BY RISK STRATIFICATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Ashraf, Tariq
    Khan, Muhammad Ishaq
    Karim, Musa
    PAKISTAN HEART JOURNAL, 2020, 53 (04): : 283 - 284
  • [24] Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques
    Zannad, Faiez
    De Backer, Guy
    Graham, Ian
    Lorenz, Matthias
    Mancia, Giuseppe
    Morrow, David A.
    Reiner, Zeljko
    Koenig, Wolfgang
    Dallongeville, Jean
    Macfadyen, Robert J.
    Ruilope, Luis M.
    Wilhelmsen, Lars
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (02) : 163 - 174
  • [25] NHS HEALTH CHECK Risk stratification could reduce costs in primary prevention of cardiovascular disease
    Dalton, Andrew R. H.
    Bull, Richard J.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [26] TREATMENT OF HYPERCHOLESTEROLEMIA IN THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE
    Diaz Rodriguez, A.
    Diaz Fernandez, B.
    Crespo Garcia, N.
    Mendez Rodriguez, E.
    Capon Alvarez, J.
    Cuello Estrada, C.
    Fernandez Alvarez, A.
    Sancuez Jaen, M.
    ATHEROSCLEROSIS, 2020, 315 : E197 - E198
  • [27] Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
    Grützmacher P.
    Öhm B.
    Szymczak S.
    Dorbath C.
    Brzoska M.
    Kleinert C.
    Clinical Research in Cardiology Supplements, 2017, 12 (Suppl 1) : 22 - 26
  • [28] Cardiovascular disease: Different strategies for primary and secondary prevention?
    Hobbs, FDR
    HEART, 2004, 90 (10) : 1217 - 1223
  • [29] Statin therapy in primary and secondary cardiovascular disease prevention
    Paparodis, Rodis D.
    Bantouna, Dimitra
    Livadas, Sarantis
    Angelopoulos, Nicholas
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 27 (01)
  • [30] A telemonitoring program for primary and secondary prevention of cardiovascular disease
    Rocco, E.
    Villa, C.
    Lupi, L.
    Triggiani, M.
    Milesi, G.
    Berlinghieri, N.
    Manerba, A.
    Papa, I.
    Dasseni, N.
    Glisenti, F.
    Nodari, S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1042 - 1043
12345